DEF 14A: Gabelli Healthcare & WellnessRx Trust Announces Annual Meeting of Shareholders

The Gabelli Healthcare & WellnessRx Trust will hold its Annual Meeting of Shareholders on May 13, 2024, to elect trustees and consider other business matters.

Summary

• The Gabelli Healthcare & WellnessRx Trust (the 'Fund') will hold its Annual Meeting of Shareholders on May 13, 2024, at 9:45 a.m., ET, both in person and via webcast.
• Shareholders will vote to elect four trustees and consider other matters.
• The record date for determining shareholders eligible to vote is March 15, 2024.
• Shareholders can vote by telephone, internet, or mail.
• The Fund's most recent annual report, including audited financial statements for the fiscal year ended December 31, 2023, is available upon request.
• A quorum requires the presence or representation by proxy of holders of one-third of the outstanding shares entitled to vote.
• As of the record date, there were 15,800,421 Common Shares, 4,000,000 shares of Series E Preferred, and 2,242,000 shares of Series G Preferred outstanding.
• Saba Capital Management, L.P. beneficially owns 5.1% of the Common Shares.
• GAMCO Investors, Inc. and affiliates beneficially own 53.3% of the Preferred Shares.
• The Board consists of ten Trustees, seven of whom are not interested persons of the Fund.
• Calgary Avansino, Leslie F. Foley, Robert C. Kolodny, and Salvatore J. Zizza have been nominated for election to serve a three-year term expiring at the 2027 Annual Meeting.
• Holders of Preferred Shares are entitled to elect two Trustees, while holders of Common Shares and Preferred Shares, voting together, elect the remaining Trustees.
• The Fund is subject to the Delaware Statutory Trust Act (DSTA) Control Share Statute, which affects voting rights of control share acquisitions.
• Shareholder proposals for the 2025 Annual Meeting must be received by December 4, 2024, for inclusion in the proxy statement, and nominations must be received between December 14, 2024, and January 13, 2025.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. It provides necessary information for shareholders to make informed decisions regarding the governance of the fund. The sentiment is slightly positive due to the routine nature of the meeting and the absence of any significant negative events or concerns.

Positives

• The Fund provides multiple avenues for shareholders to vote, including telephone, internet, and mail, enhancing accessibility.
• The Board includes a majority of independent trustees, ensuring oversight of the Fund's operations.
• The Audit Committee is composed of independent trustees and has a designated financial expert, strengthening financial oversight.
• The Fund provides detailed information on trustee qualifications and experience.
• The Fund is making its annual report available to shareholders upon request.

Negatives

• The Fund is subject to the DSTA Control Share Statute, which could potentially complicate or restrict voting rights for certain shareholders acquiring significant positions.
• The presence of interested trustees affiliated with the Adviser could raise potential conflicts of interest, although this is mitigated by the majority of independent trustees.

Risks

• The DSTA Control Share Statute could deter potential acquirers or activist investors due to voting restrictions.
• Potential conflicts of interest may arise due to the affiliation of some trustees with the Fund's Adviser.
• The Fund's reliance on key personnel, such as Mario J. Gabelli, could pose a risk if their services become unavailable.
• Market conditions and investment performance could impact the Fund's ability to attract and retain investors.

Future Outlook

The document outlines the procedures for the upcoming Annual Meeting and provides information for shareholders to participate in the governance of the Fund. It also sets deadlines for shareholder proposals and nominations for the next annual meeting.

Industry Context

This is a standard proxy statement for a closed-end fund, outlining the agenda for the annual meeting and providing information about the nominees for the board of trustees. It is typical for investment companies to solicit proxies from shareholders to vote on important matters such as the election of directors or trustees.

Comparison to Industry Standards

• The structure and content of this proxy statement are consistent with industry standards for closed-end funds.
• The disclosure of trustee qualifications, beneficial ownership, and fees paid to the independent auditor are typical of proxy statements for registered investment companies.
• The inclusion of information about the DSTA Control Share Statute is specific to Delaware statutory trusts and reflects a growing trend of funds addressing potential activist activity.
• Comparable companies such as BlackRock Health Sciences Trust (BME) and Tekla Healthcare Opportunities Fund (THQ) also issue similar proxy statements to their shareholders annually.

Stakeholder Impact

• Shareholders have the opportunity to participate in the governance of the Fund by voting on the election of trustees and other matters.
• The election of qualified trustees is intended to benefit shareholders by ensuring effective oversight of the Fund's operations and investment strategy.
• The DSTA Control Share Statute could impact the ability of certain shareholders to acquire significant positions and exercise voting rights.

Next Steps

• Shareholders should review the proxy statement and vote on the proposals.
• The Fund will hold its Annual Meeting on May 13, 2024.
• The Fund will publish the voting results in its Semiannual Report for the six months ended June 30, 2024.
• Shareholders intending to submit proposals or nominations for the 2025 Annual Meeting should adhere to the deadlines outlined in the proxy statement.

Key Dates

Keywords

Annual Meeting, Shareholders, Trustees, Proxy Statement, Gabelli Healthcare & WellnessRx Trust, Voting Rights, Preferred Shares, Common Shares, DSTA Control Share Statute, Audit Committee, Independent Trustees